chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered a booster dose past the BUD. Expiration was 1/20/22 at 1700. Vaccine was administered on 1/21/22 at 0830
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored out of range - in freezer for greater than 14 days
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis rosea
Clinical narrative: Pityriasis rosea
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: I had sore throat, chill, and coughing. I then got body ache, slight fever, and headache. I was also fatigue. These symptoms are still ongoing. The fever lasted for only a day. On Jan 20th, I was tested positive for Covid-19.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had sore throat, chill, and coughing. I then got body ache, slight fever, and headache. I was also fatigue. These symptoms are still ongoing. The fever lasted for only a day. On Jan 20th, I was tested positive for Covid-19.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injected limb mobility decreased, Injection site warmth
Clinical narrative: with administration felt a slight nerve twinge that went up the right side of my neck near the carotid, after waiting 15 minutes nothing more; after about an hour felt warm at injection site and swelling and tenderness to the right side of my clavicle, joint pain, feeling feverish but temp was wnl, headache and generalized achiness.   At approx. 2300, had chills for about 2 hours; On Saturday, still had swelling and tenderness on the right side clavicle and could barely move right arm;  Sunday still had tenderness and swelling but able to move right arm a little more but still having soreness. Monday still having tenderness and swelling at right clavicle and soreness in right arm.  Did take aleve on Sunday for pain.  On Monday, did notify workplace and my PCP of adverse reactions.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain, Pain in extremity, Pyrexia, Swelling
Clinical narrative: with administration felt a slight nerve twinge that went up the right side of my neck near the carotid, after waiting 15 minutes nothing more; after about an hour felt warm at injection site and swelling and tenderness to the right side of my clavicle, joint pain, feeling feverish but temp was wnl, headache and generalized achiness.   At approx. 2300, had chills for about 2 hours; On Saturday, still had swelling and tenderness on the right side clavicle and could barely move right arm;  Sunday still had tenderness and swelling but able to move right arm a little more but still having soreness. Monday still having tenderness and swelling at right clavicle and soreness in right arm.  Did take aleve on Sunday for pain.  On Monday, did notify workplace and my PCP of adverse reactions.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: with administration felt a slight nerve twinge that went up the right side of my neck near the carotid, after waiting 15 minutes nothing more; after about an hour felt warm at injection site and swelling and tenderness to the right side of my clavicle, joint pain, feeling feverish but temp was wnl, headache and generalized achiness.   At approx. 2300, had chills for about 2 hours; On Saturday, still had swelling and tenderness on the right side clavicle and could barely move right arm;  Sunday still had tenderness and swelling but able to move right arm a little more but still having soreness. Monday still having tenderness and swelling at right clavicle and soreness in right arm.  Did take aleve on Sunday for pain.  On Monday, did notify workplace and my PCP of adverse reactions.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills
Clinical narrative: COVID Vaccine Breakthrough Case   Pfizer Dose 1 2/20/21 (EN6200) Pfizer Dose 2 3/13/21 (EN6204) COVID Positive 10/7/21  10/7/21: Patient is a 68 year old male with past history of obesity, diabetes, atrial fibrillation on warfarin, and hyperlipidemia was admitted with worsening shortness of breath secondary to COVID-19 pneumonia. History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient has a history of atrial fibrillation for which he takes digoxin and metoprolol for rate control.  He is also on warfarin. Patient has been vaccinated for COVID-19 with the pfizer vaccine in approximately February.  Patient started feeling poorly about 1 week ago.  Start having fevers, chills, and cough.  His daughter-in-law tested positive for COVID-19 about 2 weeks ago.  He obtained a home test from the pharmacy which returned positive on Saturday.  Patient was monitoring his oxygen and was noted to be in the 80s so came to the ER today.  Oxygen saturations initially in the 70s and currently is on BiPAP at FiO2 50%.  Does desaturate with any activity.  He is not having any chest pain, nausea, vomiting, diarrhea.  Does have a poor appetite.  CT scan was performed which showed no PE but does have diffuse bilateral consolidations consistent with pneumonia.  Did have a lactic acidosis as well as elevated INR on arrival to the ER.  10/21/21:   68-year-old man who presented to the emergency department worsening shortness of breath and low oxygen saturation on pulse ox at home following recent diagnosis of COVID-19 infection.  He presented to the emergency department where his oxygen saturation was in the 70s requiring initiation of noninvasive positive pressure ventilation with BiPAP.  Chest x-ray and CT pulmonary angiogram confirmed bilateral infiltrates in keeping with COVID pneumonitis.  He was admitted to the hospital, treated with Actemra, antiviral therapy with IV remdesivir, IV steroids as well as empiric antibiotic therapy with Rocephin / azithromycin.  He continued to require high-flow oxygen and noninvasive positive pressure ventilation with BiPAP for a significant amount of time.  Gradual clinical improvement has been noted and has gradually been weaned down to supplemental oxygen at 3 liters/minute at rest.  Oxygen walk for home determination was done prior to discharge,  he was found to require no supplemental oxygen at rest per 3 liters/minutes via nasal cannula with activity.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Decreased appetite, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: COVID Vaccine Breakthrough Case   Pfizer Dose 1 2/20/21 (EN6200) Pfizer Dose 2 3/13/21 (EN6204) COVID Positive 10/7/21  10/7/21: Patient is a 68 year old male with past history of obesity, diabetes, atrial fibrillation on warfarin, and hyperlipidemia was admitted with worsening shortness of breath secondary to COVID-19 pneumonia. History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient has a history of atrial fibrillation for which he takes digoxin and metoprolol for rate control.  He is also on warfarin. Patient has been vaccinated for COVID-19 with the pfizer vaccine in approximately February.  Patient started feeling poorly about 1 week ago.  Start having fevers, chills, and cough.  His daughter-in-law tested positive for COVID-19 about 2 weeks ago.  He obtained a home test from the pharmacy which returned positive on Saturday.  Patient was monitoring his oxygen and was noted to be in the 80s so came to the ER today.  Oxygen saturations initially in the 70s and currently is on BiPAP at FiO2 50%.  Does desaturate with any activity.  He is not having any chest pain, nausea, vomiting, diarrhea.  Does have a poor appetite.  CT scan was performed which showed no PE but does have diffuse bilateral consolidations consistent with pneumonia.  Did have a lactic acidosis as well as elevated INR on arrival to the ER.  10/21/21:   68-year-old man who presented to the emergency department worsening shortness of breath and low oxygen saturation on pulse ox at home following recent diagnosis of COVID-19 infection.  He presented to the emergency department where his oxygen saturation was in the 70s requiring initiation of noninvasive positive pressure ventilation with BiPAP.  Chest x-ray and CT pulmonary angiogram confirmed bilateral infiltrates in keeping with COVID pneumonitis.  He was admitted to the hospital, treated with Actemra, antiviral therapy with IV remdesivir, IV steroids as well as empiric antibiotic therapy with Rocephin / azithromycin.  He continued to require high-flow oxygen and noninvasive positive pressure ventilation with BiPAP for a significant amount of time.  Gradual clinical improvement has been noted and has gradually been weaned down to supplemental oxygen at 3 liters/minute at rest.  Oxygen walk for home determination was done prior to discharge,  he was found to require no supplemental oxygen at rest per 3 liters/minutes via nasal cannula with activity.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, International normalised ratio increased, Lactic acidosis, Lung consolidation, Lung infiltration
Clinical narrative: COVID Vaccine Breakthrough Case   Pfizer Dose 1 2/20/21 (EN6200) Pfizer Dose 2 3/13/21 (EN6204) COVID Positive 10/7/21  10/7/21: Patient is a 68 year old male with past history of obesity, diabetes, atrial fibrillation on warfarin, and hyperlipidemia was admitted with worsening shortness of breath secondary to COVID-19 pneumonia. History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient has a history of atrial fibrillation for which he takes digoxin and metoprolol for rate control.  He is also on warfarin. Patient has been vaccinated for COVID-19 with the pfizer vaccine in approximately February.  Patient started feeling poorly about 1 week ago.  Start having fevers, chills, and cough.  His daughter-in-law tested positive for COVID-19 about 2 weeks ago.  He obtained a home test from the pharmacy which returned positive on Saturday.  Patient was monitoring his oxygen and was noted to be in the 80s so came to the ER today.  Oxygen saturations initially in the 70s and currently is on BiPAP at FiO2 50%.  Does desaturate with any activity.  He is not having any chest pain, nausea, vomiting, diarrhea.  Does have a poor appetite.  CT scan was performed which showed no PE but does have diffuse bilateral consolidations consistent with pneumonia.  Did have a lactic acidosis as well as elevated INR on arrival to the ER.  10/21/21:   68-year-old man who presented to the emergency department worsening shortness of breath and low oxygen saturation on pulse ox at home following recent diagnosis of COVID-19 infection.  He presented to the emergency department where his oxygen saturation was in the 70s requiring initiation of noninvasive positive pressure ventilation with BiPAP.  Chest x-ray and CT pulmonary angiogram confirmed bilateral infiltrates in keeping with COVID pneumonitis.  He was admitted to the hospital, treated with Actemra, antiviral therapy with IV remdesivir, IV steroids as well as empiric antibiotic therapy with Rocephin / azithromycin.  He continued to require high-flow oxygen and noninvasive positive pressure ventilation with BiPAP for a significant amount of time.  Gradual clinical improvement has been noted and has gradually been weaned down to supplemental oxygen at 3 liters/minute at rest.  Oxygen walk for home determination was done prior to discharge,  he was found to require no supplemental oxygen at rest per 3 liters/minutes via nasal cannula with activity.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pneumonia, Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID Vaccine Breakthrough Case   Pfizer Dose 1 2/20/21 (EN6200) Pfizer Dose 2 3/13/21 (EN6204) COVID Positive 10/7/21  10/7/21: Patient is a 68 year old male with past history of obesity, diabetes, atrial fibrillation on warfarin, and hyperlipidemia was admitted with worsening shortness of breath secondary to COVID-19 pneumonia. History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient has a history of atrial fibrillation for which he takes digoxin and metoprolol for rate control.  He is also on warfarin. Patient has been vaccinated for COVID-19 with the pfizer vaccine in approximately February.  Patient started feeling poorly about 1 week ago.  Start having fevers, chills, and cough.  His daughter-in-law tested positive for COVID-19 about 2 weeks ago.  He obtained a home test from the pharmacy which returned positive on Saturday.  Patient was monitoring his oxygen and was noted to be in the 80s so came to the ER today.  Oxygen saturations initially in the 70s and currently is on BiPAP at FiO2 50%.  Does desaturate with any activity.  He is not having any chest pain, nausea, vomiting, diarrhea.  Does have a poor appetite.  CT scan was performed which showed no PE but does have diffuse bilateral consolidations consistent with pneumonia.  Did have a lactic acidosis as well as elevated INR on arrival to the ER.  10/21/21:   68-year-old man who presented to the emergency department worsening shortness of breath and low oxygen saturation on pulse ox at home following recent diagnosis of COVID-19 infection.  He presented to the emergency department where his oxygen saturation was in the 70s requiring initiation of noninvasive positive pressure ventilation with BiPAP.  Chest x-ray and CT pulmonary angiogram confirmed bilateral infiltrates in keeping with COVID pneumonitis.  He was admitted to the hospital, treated with Actemra, antiviral therapy with IV remdesivir, IV steroids as well as empiric antibiotic therapy with Rocephin / azithromycin.  He continued to require high-flow oxygen and noninvasive positive pressure ventilation with BiPAP for a significant amount of time.  Gradual clinical improvement has been noted and has gradually been weaned down to supplemental oxygen at 3 liters/minute at rest.  Oxygen walk for home determination was done prior to discharge,  he was found to require no supplemental oxygen at rest per 3 liters/minutes via nasal cannula with activity.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case   Pfizer Dose 1 2/20/21 (EN6200) Pfizer Dose 2 3/13/21 (EN6204) COVID Positive 10/7/21  10/7/21: Patient is a 68 year old male with past history of obesity, diabetes, atrial fibrillation on warfarin, and hyperlipidemia was admitted with worsening shortness of breath secondary to COVID-19 pneumonia. History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient has a history of atrial fibrillation for which he takes digoxin and metoprolol for rate control.  He is also on warfarin. Patient has been vaccinated for COVID-19 with the pfizer vaccine in approximately February.  Patient started feeling poorly about 1 week ago.  Start having fevers, chills, and cough.  His daughter-in-law tested positive for COVID-19 about 2 weeks ago.  He obtained a home test from the pharmacy which returned positive on Saturday.  Patient was monitoring his oxygen and was noted to be in the 80s so came to the ER today.  Oxygen saturations initially in the 70s and currently is on BiPAP at FiO2 50%.  Does desaturate with any activity.  He is not having any chest pain, nausea, vomiting, diarrhea.  Does have a poor appetite.  CT scan was performed which showed no PE but does have diffuse bilateral consolidations consistent with pneumonia.  Did have a lactic acidosis as well as elevated INR on arrival to the ER.  10/21/21:   68-year-old man who presented to the emergency department worsening shortness of breath and low oxygen saturation on pulse ox at home following recent diagnosis of COVID-19 infection.  He presented to the emergency department where his oxygen saturation was in the 70s requiring initiation of noninvasive positive pressure ventilation with BiPAP.  Chest x-ray and CT pulmonary angiogram confirmed bilateral infiltrates in keeping with COVID pneumonitis.  He was admitted to the hospital, treated with Actemra, antiviral therapy with IV remdesivir, IV steroids as well as empiric antibiotic therapy with Rocephin / azithromycin.  He continued to require high-flow oxygen and noninvasive positive pressure ventilation with BiPAP for a significant amount of time.  Gradual clinical improvement has been noted and has gradually been weaned down to supplemental oxygen at 3 liters/minute at rest.  Oxygen walk for home determination was done prior to discharge,  he was found to require no supplemental oxygen at rest per 3 liters/minutes via nasal cannula with activity.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Pt states that he is fully vaccinated for COVId with Pfizer. Unknown dates of vaccination. Pt hospitalized with shortness of breath and tested positive for COVID upon admission
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored out of range - in freezer for greater than 14 days
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myeloid leukaemia, Asthenia, Biopsy bone marrow abnormal, Blood sodium decreased, Blood test abnormal
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/12/21 (03IL20A) Moderna Dose 2 3/12/21 (001B21A) COVID Negative 9/23/21 COVId Negative 9/26/21 COVID Positive 10/5/21  9/23/21: Patient is a 76-year-old male with a past medical history of anemia, CAD history of CABG, hypertension, myelodysplastic syndrome, history of MSSA cellulitis comes in with chief complaint of hypotension, malaise, subjective fever.  Patient also has a dental infection.  Reportedly follows with Dr. for myelodysplastic syndrome has labs drawn 2 to 3 times a week.  He went for lab draws this morning was noted to be hypotensive, febrile and felt weak with chills.  Outpatient providers as sent patient to ED for further evaluation. In the ED/blood work demonstrated hyponatremia of 125, pancytopenia, elevated CRP.  Patient received IV fluids, ceftriaxone, azithromycin, acetaminophen.  Blood pressures responded appropriately. Chest x-ray with faint left basilar opacity concerning for infiltrate.  Cultures were collected and request was made to admit to medical service for further management.  At bedside patient is sitting up comfortably in bed, denies any current lightheadedness, dizziness previously had chills but none currently no chest pain or palpitations no cough no abdominal pain though reports he did have some diarrhea few days back, has had some generalized malaise over last 2 weeks which has been getting worse.  Reports p.o. intake has been down as well.  Otherwise denies chest pain, palpitations, abdominal pain, paresthesia or swelling of extremities.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter medications.  Reports he has been compliant with prescribed medications.  No sick contacts or recent travel outside the area, family history reviewed unremarkable.  10/20/21: 76-year-old gentleman presented to the emergency room with history of fever and generalized fatigue.  Patient was noted to be neutropenic and has pneumonia.  Patient was started on empiric antibiotic therapy for pneumonia.  He was later on, a few days ago, found to be COVID-19 positive. Patient received dexamethasone, antifungal, multiple antibiotic therapies. Further evaluation with a bone marrow biopsy showed that the patient has developed acute myeloid leukemia.  After discussion with the oncologist, patient was recommended to be transferred to the another facility for further urgent management of leukemia.  However, the patient declined to go to the other facility and was debating and contemplating hospice and comfort management.  While patient was making the decision, patient opted for comfort measures.  Comfort measures were initiated.  Patient eventually passed away peacefully with his family at the bedside.  Patient passed away on October 19, 2021, at 2115.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Chest X-ray abnormal, Chills, Culture
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/12/21 (03IL20A) Moderna Dose 2 3/12/21 (001B21A) COVID Negative 9/23/21 COVId Negative 9/26/21 COVID Positive 10/5/21  9/23/21: Patient is a 76-year-old male with a past medical history of anemia, CAD history of CABG, hypertension, myelodysplastic syndrome, history of MSSA cellulitis comes in with chief complaint of hypotension, malaise, subjective fever.  Patient also has a dental infection.  Reportedly follows with Dr. for myelodysplastic syndrome has labs drawn 2 to 3 times a week.  He went for lab draws this morning was noted to be hypotensive, febrile and felt weak with chills.  Outpatient providers as sent patient to ED for further evaluation. In the ED/blood work demonstrated hyponatremia of 125, pancytopenia, elevated CRP.  Patient received IV fluids, ceftriaxone, azithromycin, acetaminophen.  Blood pressures responded appropriately. Chest x-ray with faint left basilar opacity concerning for infiltrate.  Cultures were collected and request was made to admit to medical service for further management.  At bedside patient is sitting up comfortably in bed, denies any current lightheadedness, dizziness previously had chills but none currently no chest pain or palpitations no cough no abdominal pain though reports he did have some diarrhea few days back, has had some generalized malaise over last 2 weeks which has been getting worse.  Reports p.o. intake has been down as well.  Otherwise denies chest pain, palpitations, abdominal pain, paresthesia or swelling of extremities.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter medications.  Reports he has been compliant with prescribed medications.  No sick contacts or recent travel outside the area, family history reviewed unremarkable.  10/20/21: 76-year-old gentleman presented to the emergency room with history of fever and generalized fatigue.  Patient was noted to be neutropenic and has pneumonia.  Patient was started on empiric antibiotic therapy for pneumonia.  He was later on, a few days ago, found to be COVID-19 positive. Patient received dexamethasone, antifungal, multiple antibiotic therapies. Further evaluation with a bone marrow biopsy showed that the patient has developed acute myeloid leukemia.  After discussion with the oncologist, patient was recommended to be transferred to the another facility for further urgent management of leukemia.  However, the patient declined to go to the other facility and was debating and contemplating hospice and comfort management.  While patient was making the decision, patient opted for comfort measures.  Comfort measures were initiated.  Patient eventually passed away peacefully with his family at the bedside.  Patient passed away on October 19, 2021, at 2115.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Diarrhoea, Fatigue, Hyponatraemia, Hypophagia
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/12/21 (03IL20A) Moderna Dose 2 3/12/21 (001B21A) COVID Negative 9/23/21 COVId Negative 9/26/21 COVID Positive 10/5/21  9/23/21: Patient is a 76-year-old male with a past medical history of anemia, CAD history of CABG, hypertension, myelodysplastic syndrome, history of MSSA cellulitis comes in with chief complaint of hypotension, malaise, subjective fever.  Patient also has a dental infection.  Reportedly follows with Dr. for myelodysplastic syndrome has labs drawn 2 to 3 times a week.  He went for lab draws this morning was noted to be hypotensive, febrile and felt weak with chills.  Outpatient providers as sent patient to ED for further evaluation. In the ED/blood work demonstrated hyponatremia of 125, pancytopenia, elevated CRP.  Patient received IV fluids, ceftriaxone, azithromycin, acetaminophen.  Blood pressures responded appropriately. Chest x-ray with faint left basilar opacity concerning for infiltrate.  Cultures were collected and request was made to admit to medical service for further management.  At bedside patient is sitting up comfortably in bed, denies any current lightheadedness, dizziness previously had chills but none currently no chest pain or palpitations no cough no abdominal pain though reports he did have some diarrhea few days back, has had some generalized malaise over last 2 weeks which has been getting worse.  Reports p.o. intake has been down as well.  Otherwise denies chest pain, palpitations, abdominal pain, paresthesia or swelling of extremities.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter medications.  Reports he has been compliant with prescribed medications.  No sick contacts or recent travel outside the area, family history reviewed unremarkable.  10/20/21: 76-year-old gentleman presented to the emergency room with history of fever and generalized fatigue.  Patient was noted to be neutropenic and has pneumonia.  Patient was started on empiric antibiotic therapy for pneumonia.  He was later on, a few days ago, found to be COVID-19 positive. Patient received dexamethasone, antifungal, multiple antibiotic therapies. Further evaluation with a bone marrow biopsy showed that the patient has developed acute myeloid leukemia.  After discussion with the oncologist, patient was recommended to be transferred to the another facility for further urgent management of leukemia.  However, the patient declined to go to the other facility and was debating and contemplating hospice and comfort management.  While patient was making the decision, patient opted for comfort measures.  Comfort measures were initiated.  Patient eventually passed away peacefully with his family at the bedside.  Patient passed away on October 19, 2021, at 2115.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Lung opacity, Malaise, Neutropenia, Pancytopenia
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/12/21 (03IL20A) Moderna Dose 2 3/12/21 (001B21A) COVID Negative 9/23/21 COVId Negative 9/26/21 COVID Positive 10/5/21  9/23/21: Patient is a 76-year-old male with a past medical history of anemia, CAD history of CABG, hypertension, myelodysplastic syndrome, history of MSSA cellulitis comes in with chief complaint of hypotension, malaise, subjective fever.  Patient also has a dental infection.  Reportedly follows with Dr. for myelodysplastic syndrome has labs drawn 2 to 3 times a week.  He went for lab draws this morning was noted to be hypotensive, febrile and felt weak with chills.  Outpatient providers as sent patient to ED for further evaluation. In the ED/blood work demonstrated hyponatremia of 125, pancytopenia, elevated CRP.  Patient received IV fluids, ceftriaxone, azithromycin, acetaminophen.  Blood pressures responded appropriately. Chest x-ray with faint left basilar opacity concerning for infiltrate.  Cultures were collected and request was made to admit to medical service for further management.  At bedside patient is sitting up comfortably in bed, denies any current lightheadedness, dizziness previously had chills but none currently no chest pain or palpitations no cough no abdominal pain though reports he did have some diarrhea few days back, has had some generalized malaise over last 2 weeks which has been getting worse.  Reports p.o. intake has been down as well.  Otherwise denies chest pain, palpitations, abdominal pain, paresthesia or swelling of extremities.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter medications.  Reports he has been compliant with prescribed medications.  No sick contacts or recent travel outside the area, family history reviewed unremarkable.  10/20/21: 76-year-old gentleman presented to the emergency room with history of fever and generalized fatigue.  Patient was noted to be neutropenic and has pneumonia.  Patient was started on empiric antibiotic therapy for pneumonia.  He was later on, a few days ago, found to be COVID-19 positive. Patient received dexamethasone, antifungal, multiple antibiotic therapies. Further evaluation with a bone marrow biopsy showed that the patient has developed acute myeloid leukemia.  After discussion with the oncologist, patient was recommended to be transferred to the another facility for further urgent management of leukemia.  However, the patient declined to go to the other facility and was debating and contemplating hospice and comfort management.  While patient was making the decision, patient opted for comfort measures.  Comfort measures were initiated.  Patient eventually passed away peacefully with his family at the bedside.  Patient passed away on October 19, 2021, at 2115.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pyrexia, SARS-CoV-2 test positive, Tooth abscess, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/12/21 (03IL20A) Moderna Dose 2 3/12/21 (001B21A) COVID Negative 9/23/21 COVId Negative 9/26/21 COVID Positive 10/5/21  9/23/21: Patient is a 76-year-old male with a past medical history of anemia, CAD history of CABG, hypertension, myelodysplastic syndrome, history of MSSA cellulitis comes in with chief complaint of hypotension, malaise, subjective fever.  Patient also has a dental infection.  Reportedly follows with Dr. for myelodysplastic syndrome has labs drawn 2 to 3 times a week.  He went for lab draws this morning was noted to be hypotensive, febrile and felt weak with chills.  Outpatient providers as sent patient to ED for further evaluation. In the ED/blood work demonstrated hyponatremia of 125, pancytopenia, elevated CRP.  Patient received IV fluids, ceftriaxone, azithromycin, acetaminophen.  Blood pressures responded appropriately. Chest x-ray with faint left basilar opacity concerning for infiltrate.  Cultures were collected and request was made to admit to medical service for further management.  At bedside patient is sitting up comfortably in bed, denies any current lightheadedness, dizziness previously had chills but none currently no chest pain or palpitations no cough no abdominal pain though reports he did have some diarrhea few days back, has had some generalized malaise over last 2 weeks which has been getting worse.  Reports p.o. intake has been down as well.  Otherwise denies chest pain, palpitations, abdominal pain, paresthesia or swelling of extremities.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter medications.  Reports he has been compliant with prescribed medications.  No sick contacts or recent travel outside the area, family history reviewed unremarkable.  10/20/21: 76-year-old gentleman presented to the emergency room with history of fever and generalized fatigue.  Patient was noted to be neutropenic and has pneumonia.  Patient was started on empiric antibiotic therapy for pneumonia.  He was later on, a few days ago, found to be COVID-19 positive. Patient received dexamethasone, antifungal, multiple antibiotic therapies. Further evaluation with a bone marrow biopsy showed that the patient has developed acute myeloid leukemia.  After discussion with the oncologist, patient was recommended to be transferred to the another facility for further urgent management of leukemia.  However, the patient declined to go to the other facility and was debating and contemplating hospice and comfort management.  While patient was making the decision, patient opted for comfort measures.  Comfort measures were initiated.  Patient eventually passed away peacefully with his family at the bedside.  Patient passed away on October 19, 2021, at 2115.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest pain, Confusional state, Dyspnoea
Clinical narrative: Hospitalized for COVID with shortness of breath, chest pains, weakness, and confusion on 1/16/2022.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Hospitalized for COVID with shortness of breath, chest pains, weakness, and confusion on 1/16/2022.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Asthenia, Blood glucose increased, COVID-19, Cough
Clinical narrative: This is a 70y.o. male with PMH of dementia, stroke, diabetes presenting for AMS. According to the caregiver pt's baseline of mental state was that he was oriented by his name only. He could walk by himself. He normally did not like other to touch him and he was restless sometimes. Recently he is possibly having cold. He is not eating and drinking well. This morning, the pt was found in his bathtub. He responded to his name calling but was too weak to get up. He did not talk too. His POC was 500. The caregiver said pt is not on med for diabetes. She reported pt is having dry cough but did not notice pt has fever, sob, chest pain, vomiting, or diarrhea. Denies hx of renal failure. Pt had Pfizer vaccination x 2. No booster yet.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fluid intake reduced, Hypophagia, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative
Clinical narrative: This is a 70y.o. male with PMH of dementia, stroke, diabetes presenting for AMS. According to the caregiver pt's baseline of mental state was that he was oriented by his name only. He could walk by himself. He normally did not like other to touch him and he was restless sometimes. Recently he is possibly having cold. He is not eating and drinking well. This morning, the pt was found in his bathtub. He responded to his name calling but was too weak to get up. He did not talk too. His POC was 500. The caregiver said pt is not on med for diabetes. She reported pt is having dry cough but did not notice pt has fever, sob, chest pain, vomiting, or diarrhea. Denies hx of renal failure. Pt had Pfizer vaccination x 2. No booster yet.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Mobility decreased, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: This is a 70y.o. male with PMH of dementia, stroke, diabetes presenting for AMS. According to the caregiver pt's baseline of mental state was that he was oriented by his name only. He could walk by himself. He normally did not like other to touch him and he was restless sometimes. Recently he is possibly having cold. He is not eating and drinking well. This morning, the pt was found in his bathtub. He responded to his name calling but was too weak to get up. He did not talk too. His POC was 500. The caregiver said pt is not on med for diabetes. She reported pt is having dry cough but did not notice pt has fever, sob, chest pain, vomiting, or diarrhea. Denies hx of renal failure. Pt had Pfizer vaccination x 2. No booster yet.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Rash
Clinical narrative: The evening when I got the vaccine I was very fatigued. I woke up the next day to itching on my scalp and arm. I developed a rash that started on my right nipple then up to my neck and scalp and down my right arm down to my wrist. I used 'sting-a-way' which helped for day. I went to the dr. on the 18th of Oct and the itching was getting worse. The dr. gave me hydroxyzine. After a few days of medication the rash had cleared up.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored out of range - in freezer for greater than 14 days
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Presents to the hospital secondary to worsening shortness of breath, was diagnosed with COVID-19 pneumonia first positive 8/14/2021, acute on chronic hypoxic respiratory failure secondary to infection, treated with dexamethasone, remdesivir and baricitinib. Discharge Condition: Stable and Improved. Disposition: She will be discharged today to skilled nursing unit.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiovascular evaluation, Dyspnoea, Pain in extremity
Clinical narrative: ACCORDING TO THE PATIENT'S DAUGHTER, THE PATIENT WENT SEVERAL DAYS AFTER THE VACCINE AND ON THE FOURTH DAY SHE STARTED DEVELOPING SHORTNESS OD BREATH AND PAIN IN THE ARM - AFTERWARDS SHE WENT TO THE EMERGENCY ROOM AND SHE WAS ADMITTED OVERNIGHT - THEY DID A WORKUP FOR A HEART ATTACK AND AFTER ALL WAS OVER SAID THAT IT MAY HAVE BEEN AN ADVERSE REACTION FROM THE VACCINE
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, General physical health deterioration, Malaise
Clinical narrative: Presented to th emergency department with COVID-19 like symptoms, diagnosed with acute hypoxic respiratory failure related to COVID-19. became severely ill, tx with  Lovenox Remdesivir& Baricitinib did not improve-continuously getting deteriorated discharged to inpatient hospice.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored out of range - in freezer for greater than 14 days
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt under the age requirement to receive Moderna. No adverse event was noted.  Admin worker did not notice the patient was under age when signing member into database and when asking questions.  When member arrive for his second dose it was identified he was underage and he was given Pfizer for his second MRNA to complete series.  He was told to come back in 5 months for Booster.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Developed worsened tinnitus
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Coronavirus infection, Cough, Diarrhoea, Nausea
Clinical narrative: Presents to the hospital  nausea and vomiting and diarrhea for the past 3-4 days, had a nonproductive cough,some generalized weakness. Patient incidentally found to have novel coronavirus,Not requiring oxygen.  s/p Symptomatic treatment. With mild respiratory symptoms,Infused monoclonal antibodies while in patient. Disposition:She will be discharged 8/21/2021 today to home.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory symptom, Vomiting
Clinical narrative: Presents to the hospital  nausea and vomiting and diarrhea for the past 3-4 days, had a nonproductive cough,some generalized weakness. Patient incidentally found to have novel coronavirus,Not requiring oxygen.  s/p Symptomatic treatment. With mild respiratory symptoms,Infused monoclonal antibodies while in patient. Disposition:She will be discharged 8/21/2021 today to home.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, COVID-19, Dyspnoea, Hypokalaemia
Clinical narrative: Patient is fully vaccinated. Admission dx:  shortness of breath, hypokalemia, atrial fibrillation with RVR. COVID 19. Placed on steroids with remdesivir.  Oxygen returned to room air, and placed on Xarelto and cardizem.  discharged in stable condition.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Hospitalized with a breakthrough case of COVID 19
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site swelling, Lymphadenopathy, Peripheral swelling, Skin warm
Clinical narrative: Left arm  redness, warmth, swelling, tenderness measuring 8.2 cm (L) x 6.5 cm (W), left breast redness, warmth measuring 6 cm (L) x 6.2 cm (W).  Swelling to injection site and minimal left axilla lymph node swelling
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Left arm  redness, warmth, swelling, tenderness measuring 8.2 cm (L) x 6.5 cm (W), left breast redness, warmth measuring 6 cm (L) x 6.2 cm (W).  Swelling to injection site and minimal left axilla lymph node swelling
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Chest X-ray normal, Fatigue, Full blood count normal, Headache, Influenza virus test negative
Clinical narrative: 1 hour after vaccine administration, headache while driving home requiring ambulance. Vitals normal and given motrin with improvement. Also had fever (102), fatigue and runny nose. Lasted approximately 1 week with headache and fatigue.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Lymphadenopathy, Metabolic function test, Pyrexia, Respiratory syncytial virus test negative, Rhinorrhoea
Clinical narrative: 1 hour after vaccine administration, headache while driving home requiring ambulance. Vitals normal and given motrin with improvement. Also had fever (102), fatigue and runny nose. Lasted approximately 1 week with headache and fatigue.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: SARS-CoV-2 test negative
Clinical narrative: 1 hour after vaccine administration, headache while driving home requiring ambulance. Vitals normal and given motrin with improvement. Also had fever (102), fatigue and runny nose. Lasted approximately 1 week with headache and fatigue.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG. PATIENT IS BEING REVACCINATED.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Ageusia, Anosmia, COVID-19, COVID-19 pneumonia
Clinical narrative: Presented to the ED with c/o cough for 2 months, loss of taste and smell for the past 7-10 days and a (+) COVID-19 test on 8/14- on 2 abx and prednisone.Admitted for Pneumonia due to COVID-19 virus, Acute hypoxemic respiratory failure due to COVID-19 -oxygen supplementation,steroids ,Lovenox.-Acute deep vein thrombosis of calf-bilateral- to d/c to LTAC.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Deep vein thrombosis, SARS-CoV-2 test positive
Clinical narrative: Presented to the ED with c/o cough for 2 months, loss of taste and smell for the past 7-10 days and a (+) COVID-19 test on 8/14- on 2 abx and prednisone.Admitted for Pneumonia due to COVID-19 virus, Acute hypoxemic respiratory failure due to COVID-19 -oxygen supplementation,steroids ,Lovenox.-Acute deep vein thrombosis of calf-bilateral- to d/c to LTAC.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Erythema, Nausea, Nodule
Clinical narrative: Swollen arm, red, knot on arm, dizziness, nausea, body aches, and chills.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: Swollen arm, red, knot on arm, dizziness, nausea, body aches, and chills.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored out of range - in freezer for greater than 14 days
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Syncope
Clinical narrative: ~12 hours after administration patient woke up from sleeping, felt dizzy/nauseous, then fainted. They then waited until symptoms passed, and then went back to bed.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Ear swelling, Erythema, Hypersensitivity, Musculoskeletal stiffness
Clinical narrative: I had a delayed allergic reaction in my ear. It was red, swollen, and stiff. These lasted for about a week. I went to the doctor about this. They told me that the Covid-19 vaccine can bring out new allergies. They did a full blood work and a Covid-19 test there.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: I had a delayed allergic reaction in my ear. It was red, swollen, and stiff. These lasted for about a week. I went to the doctor about this. They told me that the Covid-19 vaccine can bring out new allergies. They did a full blood work and a Covid-19 test there.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 0.42
Sex: F
Vaccine: RV5
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 22 week old infant presented to clinic with mother on 1/21/22. Mother requested that child receive only Rotavirus vaccine at this visit. Mother presented vaccine record from child's pediatrician office. Child had been vaccinated for all other age appropriate routine vaccines at pediatrician's office on 1/11/22. Mother reported that pediatrician referred her for Rotavirus vaccine because they did not have it in stock. I administered one dose of Rotateq orally during clinic visit on 1/24/22. Two hours later, I realized that the dose was given in error, due to the child's age of 22 weeks. First dose of Rotateq should not be given if child is older that 15 weeks.   I contacted  the child's mother by phone at 4:50pm on 1/21/22. I explained the error, and risk of intussusception. I provided education on warning signs of intussusception- increased fussiness, signs of abdominal pain like drawing up knees, straining, inconsolability, vomiting & changes in stool (blood or mucus in stool). Mother agreed to watch for signs and to contact pediatrician right away if she sees any in the next 7-10 days, or go to ER.  I also discussed the recommendation to complete the Rotateq series now that it has been initiated, and she agreed to return to the clinic in 4 weeks so that child can receive 2nd dose.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia
Clinical narrative: Patient experienced weakness upon admission. Patient treated with dexamethasone6 mg daily from January 14- January 20, 2022  and was on supplemental oxygen.
Age: 45.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal distension, Asthenia, Blood creatine phosphokinase, Blood lactic acid, Blood magnesium
Clinical narrative: 45-year-old male comes into the emergency department via EMS. The patient started to feel bad approximately 2 days ago where he had chills and generalized fatigue. He got a flu vaccine yesterday and his symptoms got progressively worse. He is complaining of fatigue, weakness, difficulty sleeping, chills, congestion, abdominal bloating. He slept overnight and woke up this morning. The patient went to work and when he came back home he laid down on the couch and tried to relax. His daughter looked over at him and told his wife that the patient was no longer breathing. The wife at that point time looked at her husband and saw that he was having a seizure and called EMS. She does not know exactly how long the seizure la